The price of mobotinib after reimbursement under China's national medical insurance varies depending on the specific circumstances. Choosing the generic version manufactured in India results in a relatively lower price, though the exact cost may be affected by factors such as the purchase channel and exchange rate.
Price after inclusion in medical insurance
Mobotinib is now included in the national medical insurance catalog. After reimbursement, the actual cost to patients is significantly reduced.
This price is a substantial decrease compared to the original price, alleviating the financial burden on patients requiring long-term medication.
Price of the Indian generic version
Generic versions of mobotinib (with the same brand name) are available in the Indian market.
These generic versions also come in boxes of 112 tablets, and their price is significantly lower than the version covered by medical insurance.
Important Note
The prices above are current reference information (some information is marked as 2025 and may be subject to change). Actual prices should be based on real-time quotes from local pharmacies or medical institutions.
The standard specification is 40mg*112 tablets per box; prices may vary depending on the specification or packaging.
Purchasing Indian generic drugs involves cross-border drug regulations; therefore, it is essential to carefully choose legal and compliant channels and use the medication as prescribed by your doctor. Domestic medical insurance policies and reimbursement rates vary from place to place, and the final out-of-pocket expenses need to be calculated based on the specific local conditions.
